BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36600316)

  • 1. Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality?
    von Deimling M; Koehler TC; Frye BC; Maerker-Hermann E; Venhoff N
    Ann Rheum Dis; 2023 Apr; 82(4):580-582. PubMed ID: 36600316
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody by Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis.
    Komai T; Harada H; Takahashi H; Shoda H; Fujio K
    J Clin Rheumatol; 2021 Dec; 27(8S):S806-S807. PubMed ID: 32568949
    [No Abstract]   [Full Text] [Related]  

  • 3. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
    Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
    BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic pachymeningitis in eosinophilic granulomatosis with polyangiitis.
    Izuka S; Yamashita H; Takahashi Y; Kaneko H
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):80-82. PubMed ID: 34480185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two pediatric cases of ANCA-negative eosinophilic granulomatosis with polyangiitis successfully treated with dupilumab.
    Galant-Swafford J; Geng B; Leibel S; Akuthota P; Tucker S; Cernelc-Kohan M; Sheets R; Nation J; Jefferson AA
    J Allergy Clin Immunol Pract; 2020; 8(10):3643-3646.e1. PubMed ID: 32668296
    [No Abstract]   [Full Text] [Related]  

  • 7. Eosinophilic granulomatosis with polyangiitis.
    Romero Gómez C; Hernández Negrín H; Ayala Gutiérrez MDM
    Med Clin (Barc); 2023 Apr; 160(7):310-317. PubMed ID: 36774291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANCA Glomerulonephritis and Vasculitis.
    Jennette JC; Nachman PH
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1680-1691. PubMed ID: 28842398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations on the diagnosis and treatment of anti-neutrophil cytoplasmic antibody associated vasculitis in China].
    Tian XP; Zhao LK; Jiang ZY; Wang Y; Huang CB; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1128-1135. PubMed ID: 36207967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic granulomatosis with polyangiitis.
    Villa-Forte A
    Postgrad Med; 2023 Jan; 135(sup1):52-60. PubMed ID: 36259957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and prognostic factors in an Argentinian cohort with ANCA-associated vasculitis.
    Pérez N; Gargiulo MLÁ; Suarez L; Khoury M; Gómez G
    Medicina (B Aires); 2021; 81(2):198-207. PubMed ID: 33906138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
    Yoshida Y; Nakamoto N; Oka N; Kidoguchi G; Hosokawa Y; Araki K; Ishitoku M; Watanabe H; Sugimoto T; Mokuda S; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Hirata S
    J Rheumatol; 2023 Sep; 50(9):1152-1158. PubMed ID: 37263656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ANCA-associated vasculitis].
    Krasselt ML; Holle JU
    Inn Med (Heidelb); 2022 Sep; 63(9):947-960. PubMed ID: 35925127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulomatous Vasculitis.
    Sharma A; Dogra S; Sharma K
    Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on etiopathogenesis of small vessel vasculitis].
    Arnold S; Holl-Ulrich K; Müller A; Klapa S; Lamprecht P
    Z Rheumatol; 2022 May; 81(4):270-279. PubMed ID: 35084556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANCA-negative ANCA-associated vasculitis: pitfalls of the 'vasculitis screen'.
    Cooke H; Wells M; Miller K; Medford ARL; Patel S
    Clin Med (Lond); 2023 Nov; 23(6):630-632. PubMed ID: 38065599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ANCA-Associated Vasculitides].
    Stegert M; Neumann T; Daikeler T
    Ther Umsch; 2022 Jun; 79(5):229-237. PubMed ID: 35583025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives.
    Pecher AC; Henes M; Henes JC
    Arch Gynecol Obstet; 2023 Aug; 308(2):379-385. PubMed ID: 36104505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of ANCA-associated vasculitis.
    Lenka B; Zdenka H; Eva H
    Cesk Patol; 2020; 56(2):65-67. PubMed ID: 32493021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANCA associated vasculitis (AAV): a review for internists.
    Yaseen K; Mandell BF
    Postgrad Med; 2023 Jan; 135(sup1):3-13. PubMed ID: 35831990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.